You wake up one morning and your shoulders won't move. Maybe you wait a week. In real terms, your hips ache deep in the joint, the kind of ache that makes you wonder if something's broken. Day to day, you're over 50. In real terms, two. Not "stiff" — won't move. The stiffness doesn't leave. Consider this: you figure it's just getting older. It spreads Turns out it matters..
That's how polymyalgia rheumatica starts for a lot of people. And here's the thing — if you don't treat it, it doesn't just stay uncomfortable. It can take things from you that don't come back It's one of those things that adds up..
What Is Polymyalgia Rheumatica
Polymyalgia rheumatica — PMR for short — is an inflammatory condition that hits people almost exclusively after age 50. Still, the inflammation lives in the joints and the bursae and the synovial lining around them. On the flip side, hips. Worth adding: shoulders. The name literally means "pain in many muscles," but that's misleading. The muscles themselves are fine. Neck. Sometimes wrists and knees.
It moves fast. One day you're fine. Two weeks later you can't pull a shirt over your head.
The classic presentation: bilateral shoulder and hip girdle pain and stiffness worst in the morning, lasting more than 45 minutes. Elevated inflammatory markers — ESR and CRP — almost always. A dramatic response to low-dose corticosteroids, usually within 24 to 48 hours. That response is so reliable it's practically diagnostic.
But here's what most people don't know: PMR isn't a single disease with a single cause. It's a clinical syndrome. Here's the thing — probably several different immune pathways converging on the same symptom pattern. Some researchers think it sits on a spectrum with giant cell arteritis — same patient population, same inflammatory drivers, same genetic risk factors. Day to day, about 15 to 20 percent of people with PMR develop GCA. And roughly half of GCA patients have PMR symptoms.
The peak incidence is in the 70s. Women get it two to three times more often than men. Northern European ancestry carries higher risk. Nobody knows exactly why Simple, but easy to overlook..
The immune system's wrong turn
At its core, PMR is an innate immune system malfunction. Worth adding: this recruits neutrophils and Th17 cells. Macrophages and dendritic cells in the synovium and bursae start pumping out IL-6, IL-17, TNF-alpha — the usual inflammatory suspects. The result: sterile inflammation that mimics septic arthritis without the infection.
People argue about this. Here's where I land on it.
Genetics load the gun. In practice, hLA-DRB1*04 alleles are the strongest association. Environmental triggers — maybe viral, maybe something else — pull the trigger. The immune system loses tolerance to something in the periarticular tissues and keeps attacking And that's really what it comes down to..
Why It Matters / Why People Care
Untreated PMR doesn't just hurt. It steals function.
Six months of untreated shoulder inflammation means frozen shoulders — adhesive capsulitis that can take years to resolve even after the inflammation is gone. Hip involvement leads to contractures, gait changes, falls. The muscle atrophy from disuse compounds the problem. People stop moving because it hurts. The less they move, the weaker they get. The weaker they get, the more it hurts.
I've seen patients who waited a year before seeing a rheumatologist. But by then they needed walkers. Not because of the PMR itself — because of what happened while they waited.
And then there's the giant cell arteritis shadow.
GCA is the nightmare scenario. Stroke. Here's the thing — untreated GCA causes permanent blindness in 15 to 20 percent of cases. In practice, aortic aneurysm years later. Inflammation of the large and medium arteries, especially the temporal artery and the ophthalmic artery. Death And that's really what it comes down to..
PMR and GCA aren't separate diseases — they're overlapping phenotypes. Same patient. In real terms, same genetics. Same IL-6 driven inflammation. If you have PMR, you're being screened for GCA whether you know it or not. Jaw claudication. Scalp tenderness. Which means new headache. Visual changes. But fever. Weight loss. Day to day, these aren't PMR symptoms. They're GCA warnings Surprisingly effective..
Missing GCA because you're "just treating PMR" is a catastrophic error.
What Happens When Polymyalgia Rheumatica Is Not Treated
This is the section most people skip to. Fair enough. Let's be direct.
Progressive functional decline
The stiffness doesn't plateau. Shoulders lose external rotation first — you can't wash your hair, reach a high shelf, put on a coat. Range of motion shrinks. Without treatment, the inflammatory synovitis and bursitis persist. Morning stiffness stretches from hours to all day. Hips lose extension and internal rotation — stride shortens, stairs become impossible, getting out of a car turns into a project Small thing, real impact..
Muscle atrophy follows disuse. Six months of atrophy takes months of rehab to rebuild. Now, the deltoids waste. This isn't reversible overnight. On the flip side, the gluteals flatten. Some never fully recover Still holds up..
Structural joint damage
Chronic inflammation eats cartilage. Think about it: the subchondral bone remodels. Now, erosions show up on MRI before X-ray. In long-standing untreated cases, you see glenohumeral joint space narrowing, acetabular protrusion, rotator cuff tears from mechanical impingement in a narrowed subacromial space.
These changes don't reverse with steroids. Once the architecture is gone, it's gone.
The giant cell arteritis risk
This is the one that keeps rheumatologists awake.
Fifteen to twenty percent of untreated PMR patients develop GCA. Some studies say higher. Here's the thing — the median time from PMR onset to GCA diagnosis is around 6 months — but it can happen years later. And GCA doesn't announce itself politely. Day to day, the first symptom can be sudden, painless vision loss in one eye. By the time you reach the ER, that eye is gone Practical, not theoretical..
Temporal artery biopsy stays positive for weeks after starting steroids — but not forever. Delayed treatment means missed diagnosis means missed window.
Systemic inflammation takes a toll
Persistent elevation of IL-6 and CRP isn't benign. It accelerates atherosclerosis. Increases cardiovascular event risk. Contributes to anemia of chronic disease. Worsens insulin resistance. Drives fatigue that isn't just "being tired" — it's cytokine-mediated sickness behavior Simple, but easy to overlook..
Older adults with untreated PMR have higher mortality than age-matched controls. Some of that is GCA complications. Some is cardiovascular. Some is falls and fractures from deconditioning Worth keeping that in mind. Took long enough..
The diagnostic trap
Here's what happens in practice: someone has shoulder pain. They see their PCP. Gets an X-ray — normal. Gets sent to PT. PT hurts. They see orthopedics. MRI shows "mild rotator cuff tendinopathy" or "bursitis." They get a cortisone shot. Feels better for three weeks. Comes back worse.
Six specialists later, someone checks an ESR. It's 85. CRP 42. The diagnosis takes ten minutes Small thing, real impact..
That delay? It's not rare. It's the norm. Average time to diagnosis is 3 to 6 months. In that window, all the damage above accumulates.
Common Mistakes / What Most People Get Wrong
"It's just arthritis"
Osteoarthritis doesn't cause 90-minute morning stiffness. It doesn't elevate ESR to 100. It doesn't respond to 15 mg prednisone
"It's just aging"
A 72-year-old who used to walk three miles daily doesn't suddenly develop bilateral shoulder stiffness and hip pain overnight. That said, aging causes gradual decline, not acute functional deterioration over weeks. When an older adult goes from independent to needing help dressing, bathing, or climbing stairs in a matter of months, something inflammatory is happening — not just wear and tear.
"Steroids are dangerous — I'll tough it out"
This is perhaps the most dangerous misconception. The key is proper dosing and monitoring. But untreated PMR carries equal if not greater dangers. Yes, long-term high-dose steroids carry risks. Starting at 15-20 mg prednisone daily typically brings dramatic relief within days. The goal isn't to stay on steroids indefinitely — it's to control inflammation while tapering slowly under medical supervision That's the whole idea..
The alternative isn't "natural healing." It's progressive disability, joint destruction, and potentially blindness.
"I don't need blood work — I know what this is"
Self-diagnosis based on internet research or previous experience is a recipe for disaster. Polymyalgia rheumatica can mimic numerous conditions: rotator cuff injuries, fibromyalgia, hypothyroidism, depression, even cancer. Without checking inflammatory markers (ESR, CRP), imaging to rule out other causes, and clinical correlation, you're gambling with your future mobility and vision And it works..
"One normal blood test rules it out"
Inflammation markers can be normal early in the disease course. Think about it: a patient might have classic PMR symptoms but normal ESR and CRP initially. That said, conversely, some conditions can elevate these markers without being PMR. This is why clinical judgment matters — symptoms, exam findings, and response to trial steroid therapy all play roles in diagnosis.
The Reality Check
Untreated PMR doesn't resolve on its own. Left alone, it progresses. The inflammation spreads. Which means joints deteriorate. Systemic complications emerge. What starts as "just stiffness" becomes permanent disability.
The good news? Which means pMR responds beautifully to appropriate treatment. Most patients feel dramatically better within days of starting low-dose corticosteroids. The challenge lies in getting the right diagnosis before irreversible damage occurs.
For patients experiencing persistent morning stiffness, new-onset shoulder and hip girdle pain, and unexplained fatigue — especially over age 50 — ignoring these symptoms or accepting dismissive explanations can be catastrophic. Early recognition and treatment remain the only proven strategies to prevent the cascade of complications that follow untreated disease.
The window for intervention closes quickly. By the time structural damage appears on imaging, the opportunity for complete recovery has already passed.
